Clinical picture of VITT.
Semin Hematol
; 59(2): 76-79, 2022 04.
Article
in English
| MEDLINE | ID: covidwho-1671674
ABSTRACT
This chapter explores the clinical features of vaccine-induced immune thrombotic thrombocytopenia, also called vaccine-induced immune thrombocytopenia and thrombosis (VITT). Whilst the etiology is distinct from other causes of thrombotic thrombocytopenia syndrome (TTS), presentation may be similar and hence the need for strict diagnostic criteria to ensure accurate and prompt diagnosis and early treatment. Studies have identified prognostic markers of the disease, directing therapy and management pathways, and mortality and morbidity from this rare but life-threatening and potentially disabling consequence of the ChAdOx1 nCov-19 vaccine has declined.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Thrombosis
/
Purpura, Thrombocytopenic, Idiopathic
/
COVID-19
/
ChAdOx1 nCoV-19
Type of study:
Etiology study
/
Prognostic study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Semin Hematol
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS